Hiroyuki Takamura

Dr. Hiroyuki Takamura

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Anticancer Research
Verified
Journal Article
Open access
PDF file
TMTakashi Miyata
Takashi Miyata
HTHiroyuki Takamura
Hiroyuki Takamura
RKRyosuke Kin
Ryosuke Kin
HNHisashi Nishiki
Hisashi Nishiki
AHAkifumi Hashimoto
Akifumi Hashimoto
TKTakeo Kosaka
Takeo Kosaka
Background/Aim: We evaluated whether splenic volume (SV) predicts sinusoidal obstruction syndrome (SOS) in colorectal cancer (CRC) patients receiving capecitabine plus oxaliplatin (CapeOX) therapy. Patients and Methods: In this retrospective study, we measured SV in 41 patients receiving adjuvant CapeOX for CRC at five different time points. We compared the clinical data of the 18 patients who experienced ≥30% increases in SV immediately after vs. before CapeOX (group A) with data for the remaining 23 patients (group B). Results: Platelet numbers decreased and the levels of hepatobiliary enzymes increased significantly 1 year after CapeOX compared with before CapeOX in group A. However, in group B, significantly decreased platelet numbers and significantly increased aspartate transaminase levels were confirmed only immediately after CapeOX, with no significant subsequent changes. Conclusion: SV was significantly associated with thrombocytopenia and liver dysfunction in CRC patients, and predicted SOS.

3 June 2020 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
SKShinichi Kinami
Shinichi Kinami
NNNaohiko Nakamura
Naohiko Nakamura
JZJiang Zhiyong
Jiang Zhiyong
TMTakashi Miyata
Takashi Miyata
HFHideto Fujita
Hideto Fujita
TKTakeo Kosaka
Takeo Kosaka
It has previously been suggested that postgastrectomy syndrome (PGS) is more severe in patients after surgery for advanced gastric cancer than in patients with early gastric cancer. Using the postgastrectomy syndrome assessment scale‑45 (PGSAS‑45), the present study aimed to determine whether PGS for postgastrectomy patients, in Kanazawa Medical University Hospital, with advanced gastric cancer was more severe than for patients with early gastric cancer. A questionnaire survey was conducted using PGSAS‑45 for curative gastric cancer gastrectomy cases at Kanazawa Medical University Hospital. The questionnaire data were combined with patient background data, anonymized and moved to an unlinked file for patient privacy. Using this dataset, non‑recurrent cases of distal partial gastrectomy were extracted and divided into two groups, stage IA or IB patients (group E), and stage IIA or higher (group A). The main outcome measures (MOMs) of PGSAS‑45 were compared between the two groups. The participants in the present study included 35 cases in group E and 22 cases in group A. The results of a univariate analysis to compare the MOMs between the two groups showed that only the dumping subscale was significantly different in group A and was judged to be caused by the underlying bias of the background factor. There were no MOMs with significant differences in the pathological stage based on multiple regression analyses. In cases of distal partial gastrectomy, the PGS and quality of life (QoL) of patients following advanced gastric cancer surgery were similar to those of patients with early gastric cancer. The standardized treatment for advanced gastric cancer did not induce notable postoperative failures, and QoL was not impaired. In contrast, for early‑stage gastric cancer cases, the present study suggests that it is necessary to distinguish metastasis‑negative cases to indicate an appropriate, function‑preserving curative gastrectomy.

10 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
KOKoichi Okamoto
Koichi Okamoto
TMTakashi Miyata
Takashi Miyata
TNTaigo Nagayama
Taigo Nagayama
YSYuta Sannomiya
Yuta Sannomiya
AHAkifumi Hashimoto
Akifumi Hashimoto
HTHiroyuki Takamura
Hiroyuki Takamura
Robot-assisted surgery has proven highly effective in the curative treatment of various gastrointestinal cancers. The advantages of robot-assisted surgery, including precision, enhanced operability, and magnified 3D visualization, allow surgeons to perform delicate procedures that would be challenging with conventional laparotomy or laparoscopy. These benefits make robot-assisted surgery a viable modality for treating various malignant tumors and an essential tool in curative surgery for solid cancers. Laparoscopic gastrectomy is currently the standard treatment for early gastric cancer, with numerous clinical trials assessing the efficacy of robot-assisted surgery. Although thoracoscopic esophagectomy has demonstrated advantages over open surgery in radical esophageal cancer treatment, ongoing studies are evaluating the noninferiority and potential benefits of robotic surgery. Robot-assisted surgery is also being explored for conversion surgery in cases where radical resection becomes feasible after multidisciplinary treatment and in polysurgery cases involving multiple prior laparotomies. However, establishing robust evidence for its efficacy in radical surgery for conversion and polysurgery cases remains a challenge. This narrative review discusses the advantages and limitations of robot-assisted surgery in such complex cases based on an analysis of the literature. Additionally, it examines the prospects of robotic-assisted surgery in polysurgery, metachronous remnant gastric cancer, and conversion surgery.

15 April 2020 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
ZJZhi-Yong Jiang
Zhi-Yong Jiang
SKShinichi Kinami
Shinichi Kinami
NNNaohiko Nakamura
Naohiko Nakamura
TMTakashi Miyata
Takashi Miyata
HFHideto Fujita
Hideto Fujita
TKTakeo Kosaka
Takeo Kosaka
The reliability of preoperative nodal diagnosis of advanced gastric cancer by multi-detector spiral computed tomography (MDCT) is still unclear. To examine the diagnostic ability of MDCT more precisely by using data on intranodal pathological metastatic patterns. A total of 108 patients with advanced gastric cancer who underwent MDCT and curative gastrectomy at Kanazawa Medical University Hospital were enrolled in this study. The nodal sizes measured on computed tomography (CT) images were compared with the pathology results. A receiver-operating characteristic curve was constructed, from which the critical value (CV) was calculated by using the data of the first 69 patients retrospectively. By using the CV, sensitivity and specificity were calculated with prospectively collected data from 39 consecutive patients. This enabled a more precise one-to-one correspondence of lymph nodes between CT and pathological examination by using the size data of lymph node mapping. The intranodal pathological metastatic patterns were classified into the following four types: Small nodular, peripheral, large nodular, and diffuse. Although all the cases were clinically suspected as having metastasis, 81 had lymph node metastasis and 27 had no metastasis. The number of dissected, detected on CT, and metastatic nodes were, 4241, 897, and 801, respectively. The CV obtained from the receiver-operating characteristic was 7.6 mm for the long axis. The sensitivity was 91.4% and the specificity was 47.3% in the prospective phase. The large nodular and diffuse metastases were easy to diagnose because metastatic nodes with a large axis often exhibit these forms. The ability of MDCT to contribute to a nodal diagnosis of advanced gastric cancer was examined prospectively with precise size data from node mapping, using a CV of 7.6 mm for the long axis that was calculated from the retrospectively collected data. The sensitivity was as high as 91%, and would be improved when referring to the enhanced patterns. However, its specificity was as low as 47%, because most of metastatic nodes in gastric cancer being small in size. The small nodular or peripheral type metastatic nodes were often small and considered difficult to diagnose.

1 February 1994 in Surgery Today
Verified
Journal Article
Closed access
PDF file
HKHironobu Kimura
Hironobu Kimura
HSHiroshi Sodani
Hiroshi Sodani
HTHiroyuki Takamura
Hiroyuki Takamura
KMKiichi Maeda
Kiichi Maeda
MKMasahiro Kanno
Masahiro Kanno
NSNobutaka Suzuki
Nobutaka Suzuki

1 July 2020 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
TMTakashi Miyata
Takashi Miyata
HTHiroyuki Takamura
Hiroyuki Takamura
RKRyosuke Kin
Ryosuke Kin
HNHisashi Nishiki
Hisashi Nishiki
AHAkifumi Hashimoto
Akifumi Hashimoto
TKTakeo Kosaka
Takeo Kosaka
A 48-year-old woman was admitted to our hospital because of upper abdominal pain. Computer tomography showed an enhancing mass in the pancreatic body, dilation of the main pancreatic duct (MPD) and a filling defect within the splenic vein. On the basis of the preoperative diagnosis of pancreatic body cancer, distal pancreatectomy was scheduled. The pancreas was divided along the left edge of the gastroduodenal artery; however, frozen pathological examination of the pancreatic stump was tumor positive, and therefore a total pancreatectomy was performed. The lesion was a white expansive nodular mass that had spread into the MPD and protruded into the splenic vein. A pathological diagnosis of non-functioning neuroendocrine tumor (NET) was made. In general, imaging findings of disruption of the MPD and tumor vein thrombus are characteristics of pancreatic ductal adenocarcinoma, but are uncommon in NET. However, NET should be included in the differential diagnosis for such patients.